Biosimilars Research And Analysis Report 2016

About Biosimilars

Read Sample Report @ https://www.wiseguyreports.com/sample-request/592563-global-biosimilars-market-2016-2020  

Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator’s product. They have many similarities, but are not identical to, the reference biopharmaceutical product.

analysts forecast the global biosimilars market to grow at a CAGR of 55.52% during the period 2016-2020.

Covered in this report 
The report covers the present scenario and the growth prospects of the global biosimilars market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of products such as somatropin, erythropoietin, colony-stimulating factors (CSF), interferons, interleukins, insulin and insulin analogs, follicle stimulating hormones (FSH), monoclonal antibodies (mAbs), and low molecular weight heparins (LMWH).

The market is divided into the following segments based on geography: 
• Americas 
• APAC 
• EMEA

Global Biosimilars Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market

 Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=592563

Key vendors 
• Biocon 
• Celltrion 
• Dr. Reddy's Laboratories 
• Hospira 
• Sandoz 
• STADA 
• Teva Pharmaceuticals

Other prominent vendors 
• 3SBio 
• Accord Healthcare 
• AET Biotech 
• Allergan 
• Alvartis Pharma 
• Amega Biotech 
• Amgen 
• Apotex 
• Aspen 
• AstraZeneca 
• Aurobindo Pharma 
• Baxter 
• Bharat Serums 
• Bio Sidus 
• Biogen 
• Bionovis 
• Bioton 
• BioXpress Therapeutics 
• Boehringer Ingelheim 
• Boston Oncology 
• Cipla 
• Coherus Biosciences 
• Daiichi Sankyo 
• Emcure Pharmaceuticals 
• Gedeon Richter 
• GeneScience Pharmaceuticals 
• GSK 
• Hetero Drugs 
• iBio 
• Intas Pharmaceuticals 
• JCR Pharmaceuticals 
• LG Lifesciences 
• Lonza 
• Merck 
• Mitsubishi Tanabe Pharma 
• Momenta Pharmaceuticals 
• Mylan 
• Natco Pharma 
• Novartis 
• Pfenex 
• Pfizer 
• Ranbaxy Laboratories 
• Roche Holding 
• Samsung Biologics 
• Sanofi 
• Synthon 
• Wockhardt 
• Zydus Cadila Healthcare

Market driver 
• Rise in number of patent expiries 
• For a full, detailed list, view our report

Market challenge 
• Physicians reluctance to prescribe biosimilars 
• For a full, detailed list, view our report

Market trend 
• Emergence of biosimilars 
• For a full, detailed list, view our report

 Access Report @ https://www.wiseguyreports.com/reports/592563-global-biosimilars-market-2016-2020

Key questions answered in this report 
• What will the market size be in 2020 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space? 
• What are the market opportunities and threats faced by the key vendors? 
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Contact Us:

Norah Trent

+1 646 845 9349 / +44 208 133 9349

Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym